120 related articles for article (PubMed ID: 3796535)
1. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
Caramia G; Compagnoni L; Pettinari A; Gregorini S
Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
[No Abstract] [Full Text] [Related]
2. Aztreonam in gram-negative infections in children.
Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
4. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
5. Employment of azthreonam in generalized and localized infections determined by gram negative bacteria.
Terragna A; Giacchino R; Viscoli C; Consani G
G Ital Chemioter; 1985; 32(2):423-5. PubMed ID: 3833582
[No Abstract] [Full Text] [Related]
6. Aztreonam: review of the clinical experience and potential uses in pediatrics.
Lebel MH; McCracken GH
Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
[No Abstract] [Full Text] [Related]
7. [Clinical study on aztreonam in pediatrics].
Niino M; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
[TBL] [Abstract][Full Text] [Related]
8. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
10. [Aztreonam in the treatment of nosocomial urinary infections].
Nardini A; Taddei P; Rossi F
G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
[No Abstract] [Full Text] [Related]
11. [Aztreonam in children with severe infections of the urinary tract].
Rancilio L; Assael BM; Boccazzi A; Colombo R; Crossignani R; Garlaschi L; Rusconi F
G Ital Chemioter; 1985; 32(2):437-41. PubMed ID: 3833586
[No Abstract] [Full Text] [Related]
12. [Aztreonam in the treatment of infections of the urinary tract in childhood].
Ravelli A; Fornari M; Visconti L; De Luca B; Nespoli L; Martini A
G Ital Chemioter; 1985; 32(2):427-30. PubMed ID: 3833583
[No Abstract] [Full Text] [Related]
13. [Therapeutic effects and tolerance of aztreonam in infections of the urinary tract in childhood].
Zappulla F; Mazzanti L; Sandri S; Varoli O; Bernardi F; Villa MP
G Ital Chemioter; 1985; 32(2):433-6. PubMed ID: 3833585
[No Abstract] [Full Text] [Related]
14. [Aztreonam: prevention of bacteremia in urologic surgery in patients with urinary infection].
Dalet F; del Río G; Rabinad E
Med Clin (Barc); 1988 Jan; 90(3):101-5. PubMed ID: 3352336
[No Abstract] [Full Text] [Related]
15. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
16. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
20. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
